Antimicrobial agents | Strains cohorts | P Value | |
---|---|---|---|
PLA | VAP | ||
Hypermucoviscosity | 22 (88%) | 6 (35.71%) | < 0.001 |
MDR | 12 (48%) | 11 (78.57%) | < 0.001 |
Ampicillin | 25 (100%) | 14 (100%) | Â |
Ciprofloxacin | 17 (68%) | 10 (71.29%) | Â |
Amikacin | 7 (28%) | 6 (42.85%) | < 0.001 |
Cefoperazone/sulbactam | 11 (44%) | 10 (71.43%) | < 0.001 |
Piperacillin/tazobactam | 6 (24%) | 9 (57.14%%) | < 0.001 |
Cefazolin | 15 (60%) | 5 (35.71%) | Â |
Ceftazidime | 14 (48%) | 11 (78.57%) | Â |
Cefepime | 15 (60%) | 10 (71.43%) | Â |
Cotrimoxazole | 9 (36%) | 11 (78.57%) | < 0.001 |
Imipenem | 0 | 3 (21.24%) | < 0.001 |
Meropenem | 1 (4%) | 4 (28.57%) | < 0.001 |
Polymyxin B | 0 | 1 (7.14%) | Â |
Tigecycline | 0 | 0 | Â |